GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion

Cytotherapy

Volumn 12, Issue 4, 2010, Pages 466-477

  Grisendi, Giulia ^a   Annerén, Cecilia ^b   Cafarelli, Luigi ^a   Sternieri, Rita ^a   Veronesi, Elena ^a   Cervo, Gian Luca ^a   Luminari, Stefano ^a   Maur, Michela ^a   Frassoldati, Antonio ^a   Palazzi, Giovanni ^a   Otsuru, Satoru ^c   Bambi, Franco ^d   Paolucci, Paolo ^a   Pierfranco, Conte ^a   Horwitz, Edwin ^c   Dominici, Massimo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b GE Healthcare Bio Sciences AB   (Sweden)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

1.073 g mL; Cell expansion; Density gradient media; Ficoll Paque PREMIUM; Good manufacturing practice; Mesenchymal stromal stem cells

Indexed keywords

ADIPOSE TISSUE CELL; ADULT; ARTICLE; CARTILAGE; CELL ISOLATION; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMING UNIT F; DENSITY GRADIENT; EX VIVO STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GOOD MANUFACTURING PRACTICE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION;

EID: 77954439580     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653241003649510     Document Type: Article

References (37)

1. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luri á EA, Ruadkow. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2:83-92.
2. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317
3. Müller I, Kordowich S, Holzwarth C Spano C, Isensee G, Staiber A, et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy. 2006;8:437-444
4. Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol. 2008; 36:1035-1046
5. Martinez C, Hofmann TJ, Marino R., Dominici M, Horwitz EM. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood. 2007;109:4245-4248
6. Ko ç̧ ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307-316
7. Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells Mol Dis. 2008;40:25-32.
8. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 2002;1:92-100.
9. Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol. 2005;100:471-481
10. El-Badri NS, Maheshwari A, Sanberg PR. Mesenchymal stem cells in autoimmune disease. Stem Cells Dev. 2004;13: 463-472
11. Horwitz EM. Marrow mesenchymal cell transplantation for genetic disorders of bone. Cytotherapy. 2001;3:399-401.
12. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira- Hansen M, Bekele BN, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004;96:1593-1603
13. Hong X, Miller C, Savant-Bhonsale S, Kalkanis SN. Antitumor treatment using interleukin-12 secreting marrow stromal cells in an invasive glioma model. Neurosurgery. 2009;64: 1139-1147
14. Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT. Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells. 2003;21:389-404.
15. Castro-Malaspina H, Gay RE, Resnick G, Kapoor, Kapoor N, Meyers P, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289-301.
16. Dominici M, Luppi M, Campioni D, Lanza F, Barozzi P, Milani R, et al. PCR with degenerate primers for highly conserved DNA polymerase gene of the herpes virus family shows neither human herpes virus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients. Int J Cancer. 2000;86:76-82.
17. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932-8937
18. Purpura KA, Aubin JE, Zandstra PW. Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells. 2004;22:39-50.
19. Dimitriou H, Linardakis E, Martimianaki G, Stiakaki E, Perdikogianni CH, Charbord P, et al. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy. 2008;10:125-133
20. Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Gué rin JJ, Pigeon P, et al. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol. 2005;33:219-225
21. Jones EA, English A, Kinsey SE, Straszynski L, Emery P, Ponchel F, et al. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom. 2006;15:391-399
22. Jarocha D, Lukasiewicz E, Majka M. Advantage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells. Folia Histochem Cytobiol. 2008;46:307-314
23. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301-313
24. Delorme B, Ringe J, Gallay N, Le Vern Y, Kerboeuf D, Jorgensen C, et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood. 2008;111:2631-2635
25. Janderová L, McNeil M, Murrell AN, Mynatt RL, Smith SR. Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res. 2003;11:65-74.
26. Corre J, Mahtouk K, Attal M, Gadelorge M, Huynh A, Fleury-Cappellesso S, et al. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia. 2007;21: 1079-1088
27. Mutin M, Dignat-George F, Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens. 1997;50:449-458
28. Poncelet P, George F, Papa S, Lanza F. Quantitation of hemopoietic cell antigens in flow cytometry. Eur J Histochem. 1996;40(Suppl 1):15-32.
29. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418:41-49
30. Horn P, Bork S, Diehlmann A Walenda T, Eckstein V, Ho AD, Wagner W. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy. 2008;10: 676-685
31. Carrancio S, Ló p ez-Holgado N, Sá n chez-Guijo FM, Villaró n E, Barbado V, Tabera S, et al. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008;36:1014-1021
32. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood). 2001;226:507-520
33. Lange C, Schroeder J, Stute N, Lioznov MV, Zander AR et al. High-potential human mesenchymal stem cells. Stem Cells Dev. 2005;14:70-80.
34. Campioni D, Lanza F, Moretti S, Dominici M, Punturieri M, Pauli S, et al. Functional and immunophenotypic characteristics of isolated CD105(+) and fibroblast(+) stromal cells from AML: implications for their plasticity along endothelial lineage. Cytotherapy. 2003;5:66-79.
35. Campioni D, Punturieri M, Bardi A, Moretti S, Tammiso E, Lanza F, Castoldi G. ' In vitro ' evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach. Leuk Res. 2004;28:9-17.
36. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA. 1992;89:2804-2808
37. Xu J, Liao WB, Gu DS, Liang L, Liu M, Du W, et al. Neural ganglioside GD2 identifies a subpopulation of mesenchymal stem cells in umbilical cord. Cell Phis Bioch. 2009; 23:415-424